Ipamorelin is a selective growth hormone secretagogue that stimulates GH release without significantly affecting cortisol or prolactin levels.
Ipamorelin is a synthetic pentapeptide growth hormone secretagogue with high selectivity for GH release. Unlike other GH secretagogues, it does not significantly stimulate cortisol or prolactin secretion. Researchers study Ipamorelin for its selective GH-releasing properties and favorable side effect profile in laboratory settings.
Research on Ipamorelin focuses on its selective growth hormone releasing effects and receptor specificity. Studies examine its influence on GH pulse amplitude, IGF-1 production, and metabolic parameters without affecting stress hormones. Researchers investigate its mechanisms involving selective ghrelin receptor activation and minimal desensitization compared to other secretagogues in experimental models.
For laboratory research purposes only. Not for human consumption or clinical use. This product is intended solely for in-vitro research and educational applications.

Explore similar peptides and compounds that researchers often study together